製剤開発アウトソーシングの世界市場レポート 2024年

製剤開発アウトソーシング市場規模は近年力強く成長しています。2023年の274億9,000万米ドルから2024年には301億7,000万米ドルへと、CAGR9.7％で拡大します。過去数年間における成長は、コスト効率の達成、コア・コンピタンスの重視、規制遵守の徹底、医薬品開発の迅速化、専門知識の獲得などに起因しています。

製剤開発アウトソーシング市場もまた、医薬品需要の増加により成長が見込まれています。医薬品は、医療、疾病予防、症状緩和、レクリエーションなどの目的で使用される物質であり、医療産業の中心的存在です。製剤開発アウトソーシングは医薬品開発において重要な役割を果たしており、バイオ医薬品や新規ドラッグデリバリーシステムの開発などの活動をサポートし、医薬品開発プロセスを加速させ、製薬会社にコスト効率の高いソリューションを提供しています。2022年4月、フィアス・医療によると、米国の医薬品支出総額は2021年に7.7%増の5,769億米ドルに達し、2022年には4%から6%増加すると予測されています。そのため、医薬品需要の拡大が製剤開発アウトソーシング市場の成長を牽引する重要な要因となっています。

2023年の製剤開発アウトソーシング世界市場で最大の地域は北米でした。製剤開発アウトソーシング市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の製剤開発アウトソーシング市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の製剤開発アウトソーシングの市場規模実績と成長、2018～2023年
• 世界の製剤開発アウトソーシング市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の製剤開発アウトソーシング市場、サービス別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 前配合
• 製剤開発
• 世界の製剤開発アウトソーシング市場、治療領域別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 腫瘍学
• 感染症
• 神経内科
• 血液学
• 呼吸器系
• 心臓血管
• 皮膚科
• その他の治療法
• 世界の製剤開発アウトソーシング市場、製剤別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 経口
• 注射
• 局所
• その他の処方
• 世界の製剤開発アウトソーシング市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 製薬産業
• 研究と学術開発

第7章 地域と国の分析

• 世界の製剤開発アウトソーシング市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の製剤開発アウトソーシング市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 製剤開発アウトソーシング市場の競合情勢
• 製剤開発アウトソーシング市場企業プロファイル
  • Syngene International Ltd.
  • Aizant Drug Research Solutions Private Limited.
  • Catalent Inc.
  • Intertek Group plc
  • Recipharm AB

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の展望と潜在性分析

第35章 付録

“Formulation Development Outsourcing Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on formulation development outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for formulation development outsourcing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The formulation development outsourcing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Service: Preformulation; Formulation Development
• 2) By Therapeutic Area: Oncology; Infectious Disease; Neurology; Hematology; Respiratory; Cardiovascular; Dermatology; Other Therapeutics
• 3) By Formulation: Oral; Injectable; Topical; Other Formulations
• 4) By End-User: Pharmaceutical Industries; Research And Academic Development
• Companies Mentioned: Syngene International Ltd.; Aizant Drug Research Solutions Private Limited.; Catalent Inc.; Intertek Group plc; Recipharm AB
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Formulation development outsourcing involves the practice of enlisting external experts or organizations to manage the formulation and development process of a product. This outsourcing arrangement enables companies to tap into the specialized knowledge, resources, and expertise of external parties for the development or enhancement of their product formulations.

The primary services offered in formulation development outsourcing include pre-formulation and formulation development. Pre-formulation pertains to the developmental stage in pharmaceutical formulations, encompassing various therapeutic areas such as oncology, infectious disease, neurology, hematology, respiratory, cardiovascular, dermatology, among others. These formulations cover diverse administration methods, including oral, injectable, topical, and others. Formulation development outsourcing is utilized by various end-users, including pharmaceutical industries, research entities, and academic development.

The formulation development outsourcing research report is one of a series of new reports from The Business Research Company that provides formulation development outsourcing statistics, including formulation development outsourcing industry global market size, regional shares, competitors with a formulation development outsourcing share, detailed formulation development outsourcing segments, market trends, and opportunities, and any further data you may need to thrive in the formulation development outsourcing industry. This formulation development outsourcing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The formulation development outsourcing market size has grown strongly in recent years. It will grow from $27.49 billion in 2023 to $30.17 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historical period can be ascribed to achieving cost efficiency, emphasizing core competencies, ensuring regulatory compliance, expediting drug development, and gaining access to specialized expertise.

The formulation development outsourcing market size is expected to see strong growth in the next few years. It will grow to $43.64 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The anticipated growth in the forecast period can be linked to the heightened complexity of drug molecules, strategic partnerships, the escalation of R&D costs, innovations in biopharmaceuticals, and the demand for flexible capacity. Noteworthy trends in the forecast period encompass the integration of continuous manufacturing processes, outsourcing for modified-release formulations, collaborations for specialized drug delivery systems, the incorporation of regulatory expertise in outsourced services, and the utilization of artificial intelligence (AI) in formulation design.

The anticipated growth in the formulation development outsourcing market is expected to be driven by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting a year or longer and necessitating ongoing medical care, significantly impact daily activities. The development of effective formulations and therapies for managing and treating these conditions requires specialized expertise and resources. Formulation development outsourcing involves the engagement of external experts or specialized firms to handle the research, development, and optimization of drug formulations aimed at treating chronic diseases. For example, in September 2022, as reported by the World Health Organization, chronic diseases annually affect 41 million people globally, constituting 74% of all deaths worldwide. Additionally, according to the Australian Institute of Health and Welfare, 47% of the Australian population, or 11.6 million individuals, had one or more chronic illnesses in 2020-21. Consequently, the rising prevalence of chronic diseases is a key driver for the growth of the formulation development outsourcing market.

The formulation development outsourcing market is also expected to witness growth due to the increasing demand for drugs. Drugs, substances used for medical treatment, disease prevention, symptom relief, or recreational purposes, are central to the healthcare industry. Formulation development outsourcing plays a crucial role in drug development, supporting activities such as the development of biopharmaceuticals and novel drug delivery systems, accelerating the drug development process, and providing a cost-effective solution for pharmaceutical companies. In April 2022, according to Fierce Healthcare, total drug expenditure in the United States witnessed a 7.7% growth in 2021, reaching $576.9 billion, and is projected to experience an estimated increase ranging from 4% to 6% in 2022. Therefore, the growing demand for drugs is a significant factor driving the growth of the formulation development outsourcing market.

Technological advancements represent a prominent trend gaining traction in the formulation development outsourcing market. Companies within this market are embracing cutting-edge technologies, such as artificial intelligence (AI) and machine learning (ML), to maintain their competitive positions. For example, in March 2023, Nvidia, a US-based software technology company, introduced BioNeMo Cloud, a novel component in their AI Foundations suite. This service grants researchers access to pre-trained AI models, facilitating customization with private data to expedite life sciences research, drug discovery, and protein engineering. Notably, industry leaders such as Amgen and numerous startups are leveraging this technology as a cloud service, accelerating drug development processes.

Major players in the formulation development outsourcing market are strategically focusing on enhancing various outsourcing capabilities, including method development. Method development capabilities denote an organization's or laboratory's expertise, skills, and resources to create, optimize, and validate analytical methods for analyzing various substances. For instance, in February 2022, Berkshire Sterile Manufacturing (BSM), a US-based sterile filling contract manufacturer, bolstered its clients' drug production capabilities by incorporating formulation, lyophilization, and method development expertise. BSM is expanding its services to cover first-in-human formulation development, providing materials for preclinical studies, and conducting research-level stability studies. Additionally, BSM is offering services for formulation optimization, process development, optimization, and scale-up studies, utilizing materials and equipment indicative of future Good Manufacturing Practice (GMP) manufacturing.

In August 2022, Catalent Inc., a US-based pharmaceutical company, completed the acquisition of Metrics Inc. for $475 million. This strategic move broadened, diversified, and enriched Catalent's portfolio by adding capabilities in integrated oral solid formulation development, manufacturing, and packaging. This expansion aims to assist customers in simplifying and accelerating their programs while enhancing their capacity to handle highly potent compounds. Metrics Inc. is a US-based global pharmaceutical formulation development organization specializing in novel oral dosage forms.

Major companies operating in the formulation development outsourcing market report are Syngene International Ltd., Aizant Drug Research Solutions Private Limited., Catalent Inc., Intertek Group plc, Recipharm AB, SGS S.A., Lonza Group AG, Eurofins Scientific SE, Laboratory Corporation of America Holdings, Charles River Laboratories International Inc., Emergent Biosolutions Inc., IRISYS LLC, Piramal Pharma Limited., Biocon Limited., Dr Reddy's Laboratories Ltd., Quotient Sciences Ltd., Almac Group, Patheon, Evonik Industries AG, Metrics Contract Services, Aenova Group, Fareva Group, Vetter Pharma International GmbH, Aesica Pharmaceuticals, WuXi AppTec, Formosa Laboratories Inc., Aptuit LLC, ProPharma Group, Laurus Labs Limited, Petrofly

North America was the largest region in the global formulation development outsourcing market in 2023. The regions covered in the formulation development outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the formulation development outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The formulation development outsourcing market includes revenues earned by entities by providing services such as ingredient sourcing, stability studies, analytical testing, and regulatory support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Formulation Development Outsourcing Market Characteristics

3. Formulation Development Outsourcing Market Trends And Strategies

4. Formulation Development Outsourcing Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Formulation Development Outsourcing Market Size and Growth

• 5.1. Global Formulation Development Outsourcing Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Formulation Development Outsourcing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Formulation Development Outsourcing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Formulation Development Outsourcing Market Segmentation

• 6.1. Global Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Preformulation
• Formulation Development
• 6.2. Global Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oncology
• Infectious Disease
• Neurology
• Hematology
• Respiratory
• Cardiovascular
• Dermatology
• Other Therapeutics
• 6.3. Global Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Injectable
• Topical
• Other Formulations
• 6.4. Global Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceutical Industries
• Research And Academic Development

7. Formulation Development Outsourcing Market Regional And Country Analysis

• 7.1. Global Formulation Development Outsourcing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Formulation Development Outsourcing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Formulation Development Outsourcing Market

• 8.1. Asia-Pacific Formulation Development Outsourcing Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Formulation Development Outsourcing Market

• 9.1. China Formulation Development Outsourcing Market Overview
• 9.2. China Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Formulation Development Outsourcing Market

• 10.1. India Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Formulation Development Outsourcing Market

• 11.1. Japan Formulation Development Outsourcing Market Overview
• 11.2. Japan Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Formulation Development Outsourcing Market

• 12.1. Australia Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Formulation Development Outsourcing Market

• 13.1. Indonesia Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Formulation Development Outsourcing Market

• 14.1. South Korea Formulation Development Outsourcing Market Overview
• 14.2. South Korea Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Formulation Development Outsourcing Market

• 15.1. Western Europe Formulation Development Outsourcing Market Overview
• 15.2. Western Europe Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Formulation Development Outsourcing Market

• 16.1. UK Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Formulation Development Outsourcing Market

• 17.1. Germany Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Formulation Development Outsourcing Market

• 18.1. France Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Formulation Development Outsourcing Market

• 19.1. Italy Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Formulation Development Outsourcing Market

• 20.1. Spain Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Formulation Development Outsourcing Market

• 21.1. Eastern Europe Formulation Development Outsourcing Market Overview
• 21.2. Eastern Europe Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Formulation Development Outsourcing Market

• 22.1. Russia Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Formulation Development Outsourcing Market

• 23.1. North America Formulation Development Outsourcing Market Overview
• 23.2. North America Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Formulation Development Outsourcing Market

• 24.1. USA Formulation Development Outsourcing Market Overview
• 24.2. USA Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Formulation Development Outsourcing Market

• 25.1. Canada Formulation Development Outsourcing Market Overview
• 25.2. Canada Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Formulation Development Outsourcing Market

• 26.1. South America Formulation Development Outsourcing Market Overview
• 26.2. South America Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Formulation Development Outsourcing Market

• 27.1. Brazil Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Formulation Development Outsourcing Market

• 28.1. Middle East Formulation Development Outsourcing Market Overview
• 28.2. Middle East Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Formulation Development Outsourcing Market

• 29.1. Africa Formulation Development Outsourcing Market Overview
• 29.2. Africa Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Formulation Development Outsourcing Market Competitive Landscape And Company Profiles

• 30.1. Formulation Development Outsourcing Market Competitive Landscape
• 30.2. Formulation Development Outsourcing Market Company Profiles
  • 30.2.1. Syngene International Ltd.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Aizant Drug Research Solutions Private Limited.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Catalent Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Intertek Group plc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Recipharm AB
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Formulation Development Outsourcing Market Competitive Benchmarking

32. Global Formulation Development Outsourcing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Formulation Development Outsourcing Market

34. Formulation Development Outsourcing Market Future Outlook and Potential Analysis

• 34.1 Formulation Development Outsourcing Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Formulation Development Outsourcing Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Formulation Development Outsourcing Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer